Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Xin actin-binding repeat-containing protein 1 (XIRP1) is a striated muscle cytoskeletal protein highly expressed in the heart, where it stabilizes actin filaments and organizes cell adhesion components at the intercalated disk[2][1]. XIRP1 acts as a scaffolding protein, directly interacting with actin and key junctional and signaling proteins such as filamin, cortactin, β-catenin, and KChIP2, which are essential for the correct localization and function of cardiac ion channels that govern cardiac action potential and conduction[1]. Loss of XIRP1 results in disrupted cardiac intercalated disk architecture, decreased density and mislocalization of ion channels, and impaired cardiac electrophysiology, with knockout mouse models developing arrhythmias, conduction defects, and structural cardiomyopathy[1][2][3]. In human genetics, rare deleterious variants in XIRP1 have been associated with Brugada syndrome and sudden unexplained nocturnal death syndrome; XIRP1 is considered a candidate gene for inherited cardiac arrhythmia disorders[1][3]. XIRP1 also contributes to normal skeletal muscle structure, injury recovery, and muscle satellite cell activation[2]. Note: No current drugs directly target XIRP1, and no mechanisms of action for drugs on this protein are described in existing literature. It is classified as a "candidate target" due to genetic evidence linking its function to cardiac disease[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Xin actin-binding repeat-containing protein 1 (XIRP1).